Long‐term exposure to monoclonal anti‐TNF is associated with an increased risk of lymphoma in BAFF‐transgenic mice

The impact of treatment on the risk of lymphoma in patients with rheumatoid arthritis (RA) is unclear. Here, we aimed to assess if the risk of lymphoma differs according to the type of tumor necrosis factor inhibitor (TNFi), comparing monoclonal anti‐TNF antibodies to the soluble TNF receptor. We us...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Exp Immunol
Autori principali: Nocturne, Gaetane, Ly, Bineta, Paoletti, Audrey, Pascaud, Juliette, Seror, Raphaele, Nicco, Carole, Mackay, Fabienne, Vincent, F.B., Lazure, Thierry, Ferlicot, Sophie, Stimmer, Lev, Pascal, Quentin, Roulland, Sandrine, Krzysiek, Roman, Hacein‐Bey, Salima, Batteux, Frederic, Mariette, Xavier
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2021
Soggetti:
ORIGINAL ARTICLES
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8274188/
https://ncbi.nlm.nih.gov/pubmed/33864242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13602
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi